FDA Inspection 717989 — LPNA Group Inc.

LPNA Group Inc. — FEI 1000120219

The FDA completed an inspection of LPNA Group Inc. on Mar 7, 2011 in Tonawanda, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 7, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tonawanda, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.